drugset / Trial / NCT00617045
Duloxetine for the Treatment of Postpartum Depression
Withdrawn
Yale University
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.
Timeline
- Start
- 2007-07
- Primary completion
- 2012-12
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | Oral |